Hutchmed

This early-stage study tested the safety and appropriate dosage of an experimental oral drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The trial enrolled 42 adults whose cancer had progressed after standard treatments…

This early-stage study tested an oral drug called HMPL-306 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. The trial focused on patients whose cance…

This early-stage study tested a new oral drug called HMPL-523 in adults with lymphoma that had returned or stopped responding to all approved treatments. The main goals were to find a safe dose and see how the body processes the drug. The study was terminated and did not proceed …